Unexplained week‐to‐week variation in BNP and NT‐proBNP is low in chronic heart failure patients during steady state

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Journal of Heart Failure

• Publication date

  2007-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejheart.2006.05.001PMID 16829184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NTproBNP‐guided drug treatment for chronic heart failure: design and methods in the “BATTLESCARRED” trial

  2006cited by this paper
• The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

  2005cited by this paper
• Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.

  2005cited by this paper
• How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

  2005cited by this paper
• Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure.

  2005cited by this paper
• Power function of the reference change value in relation to cut-off points, reference intervals and index of individuality

  2005cited by this paper
• Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes.

  2004cited by this paper
• Determination of reference intervals for serum creatinine, creatinine excretion and creatinine clearance with an enzymatic and a modified Jaffé method.

  2004cited by this paper
• Basal and exercise‐induced neuroendocrine activation in patients with heart failure and in normal subjects

  2004cited by this paper
• Multicenter analytical performance evaluation of the Elecsys® proBNP assay

  2004cited by this paper
• Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes.

  2004cited by this paper
• The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation

  2004cited by this paper
• Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion.

  2004influential reference
• Reference change values and power functions

  2004influential reference
• Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study.

  2004cited by this paper
• High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.

  2004influential reference
• NT‐proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT‐proBNP substudy

  2004cited by this paper
• Increased cardiac BNP expression associated with myocardial ischemia

  2003cited by this paper
• Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

  2003influential reference
• Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure.

  2003cited by this paper
• Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure.

  2003influential reference
• An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area.

  2002cited by this paper
• Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

  2002cited by this paper
• Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure.

  2002influential reference
• The regulation and measurement of plasma volume in heart failure.

  2002cited by this paper
• Influence of Index of Individuality on False Positives in Repeated Sampling from Healthy Individuals

  2001influential reference
• Optimal analytical performance for point of care testing.

  2001cited by this paper
• Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure.

  2001cited by this paper
• Deconvolution Analysis of Cardiac Natriuretic Peptides During Acute Volume Overload

  2000cited by this paper
• Biological variation of glucose and insulin includes a deterministic chaotic component.

  1999cited by this paper
• Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.

  1999influential reference
• Long-range correlations of serial FEV1 measurements in emphysematous patients and normal subjects.

  1998influential reference
• Biochemical detection of left-ventricular systolic dysfunction.

  1998cited by this paper
• Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.

  1997cited by this paper
• Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients.

  1994influential reference
• Patterns of beat-to-beat heart rate variability in advanced heart failure.

  1992cited by this paper
• Dietary sodium loading increases plasma brain natriuretic peptide levels in man.

  1991influential reference
• Chaos and fractals in human physiology.

  1990cited by this paper
• Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia

  1990cited by this paper
• Generation and application of data on biological variation in clinical chemistry.

  1989influential reference
• On the calculation of a "reference change" for comparing two consecutive measurements.

  1983cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Effects of intra- and interindividual variation on the appropriate use of normal ranges.

  1974cited by this paper

• Variation of brain natriuretic peptide assists with volume management and predicts prognosis of hemodialysis patients.

  2024cites this paper
• The association between kidney function, cognitive function, and structural brain abnormalities in community-dwelling individuals aged 50+ is mediated by age and biomarkers of cardiovascular disease

  2023cites this paper
• Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes

  2022cites this paper
• Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure

  2021cites this paper
• Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction

  2020cites this paper
• Incremental prognostic value of a novel metabolite‐based biomarker score in congestive heart failure patients

  2020cites this paper
• Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study

  2020cites this paper
• Visit-to-Visit B-Type Natriuretic Peptide Variability during the Previous Year Has Independent Prognostic Value in Patients with Stable Chronic Heart Failure

  2019cites this paper
• Роль натрийуретических пептидов в определении тактики ведения недоношенных новорожденных с гемодинамически значимым функционирующим артериальным протоком

  2019cites this paper
• Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)

  2019cites this paper
• Change in NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Level and Risk of Dementia in Multi-Ethnic Study of Atherosclerosis (MESA)

  2019cites this paper
• Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.

  2019cites this paper
• Effects of a Higher Heart Rate on Quality of Life and Functional Capacity in Patients With Left Ventricular Diastolic Dysfunction.

  2019cites this paper
• Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides.

  2018cites this paper
• Minute Myocardial Injury as Measured by High-Sensitive Troponin T Serum Levels Predicts the Response to Intracoronary Infusion of Bone Marrow-Derived Mononuclear Cells in Patients With Stable Chronic Post-Infarction Heart Failure: Insights From the TOPCARE-CHD Registry

  2017cites this paper
• Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care?

  2017cites this paper
• NT-proBNP as Marker of Ventricular Dilatation and Pulmonary Regurgitation After Surgical Correction of Tetralogy of Fallot: A MRI Validation Study

  2017cites this paper
• Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome.

  2017cites this paper
• Hemodynamic Determinants of the Biologic Variation of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Stable Systolic Chronic Heart Failure.

  2017influential citation
• [Therapy of High Risk Patients After Decompensation of Heart Failure Under NT-proBNP Control. Main Results].

  2016cites this paper
• THE DIAGNOSTIC INTEREST AND STRATIFICATION OF NT-PROBNP IN THE CORONARY SYNDROME

  2016cites this paper
• Unrecognized myocardial infarction and cardiac biochemical markers in patients with stable coronary artery disease

  2016influential citation
• Air pollution exposure and novel biomarkers of inflammation and cardiac stress in the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air)

  2016cites this paper
• Biomarker Guided Therapy in Chronic Heart Failure.

  2015cites this paper
• Biologic variability in NT-proBNP and cardiac troponin-I in healthy dogs and dogs with mitral valve degeneration.

  2015cites this paper
• Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).

  2015cites this paper
• Calcium channel blockers improve exercise capacity and reduce N-terminal ProB-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation

  2014cites this paper
• Natriuretic Peptides for Diagnosis, Prognosis, and Management of Heart Failure

  2014cites this paper
• Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.

  2014cites this paper
• Serial measurements of the Nt-ProBNP during the dry state in patients with systolic heart failure are predictors of the long-term prognosis

  2014influential citation
• Determinants of N-Terminal Pro-Brain Natriuretic Peptide Variation in Hemodialysis Patients and Prediction of Survival

  2014cites this paper
• Importance of Bnp changes during the follow-up in elderly outpatients with heart failure.

  2014cites this paper
• Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation.

  2014cites this paper
• Temporal trajectory of B-type natriuretic peptide in patients with CKD stages 3 and 4, dialysis, and kidney transplant.

  2014cites this paper
• The Role of Natriuretic Peptides as Biomarkers for Guiding the Management of Chronic Heart Failure

  2013cites this paper
• The Role of B-Type Natriuretic Peptide Testing in Guiding Outpatient Heart Failure Treatment

  2013cites this paper
• Use of Natriuretic Peptide Measurement in the Management of Heart Failure

  2013cites this paper
• Early NT‐proBNP Decrease With Ivabradine in Ambulatory Patients With Systolic Heart Failure

  2013cites this paper
• Challenges in Routine Clinical Chemistry Analysis: Proteins and Enzymes

  2013cites this paper
• Short- and long-term individual variation in NT-proBNP levels in patients with stable coronary artery disease.

  2013cites this paper
• [Treatment of patients with chronic heart failure based on monitoring of concentrations of natriuretic peptides--to what extent it is justified in clinical practice?].

  2013cites this paper
• Advantages of the lognormal approach to determining reference change values for N-terminal propeptide B-type natriuretic peptide.

  2012cites this paper
• Natriuretic peptide testing for predicting adverse events following heart failure hospitalization.

  2012cites this paper
• The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use.

  2012cites this paper
• Le NT-proBNP dans l’insuffisance cardiaque des sujets noirs africains : quels seuils faut-il retenir en ambulatoire ?

  2012cites this paper
• Biological variability of C-reactive protein and specific canine pancreatic lipase immunoreactivity in apparently healthy dogs.

  2011cites this paper
• Relationship between biological variation in B-type natriuretic peptide and plasma renin concentration in stable outpatients with dilated cardiomyopathy.

  2011cites this paper
• Physiopathologic Correlates of Intrathoracic Impedance in Chronic Heart Failure Patients

  2011cites this paper
• Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care

  2011cites this paper
• Biological variation of brain natriuretic peptide and cardiac events in stable outpatients with nonischemic chronic heart failure.

  2011cites this paper
• FGF-23 und linksventrikuläre Dysfunktion

  2011cites this paper
• Biomarkers in heart failure: a clinical review

  2010cites this paper
• Post-discharge changes in NT-proBNP and quality of life after acute dyspnea hospitalization as predictors of one-year outcomes.

  2010cites this paper
• Biomarkers in the Management of Heart Failure

  2010cites this paper
• Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.

  2010cites this paper
• Biomarker guided therapy for heart failure: focus on natriuretic peptides

  2010cites this paper
• Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment

  2009cites this paper
• Variability of N-terminal probrain natriuretic peptide in stable chronic heart failure and its relation to changes in clinical variables.

  2009cites this paper
• N-Terminal-pro-B-type Natriuretic Peptide during Pharmacological Heart Rate Reduction in Hyperthyroidism

  2009cites this paper
• Reference change values and determinants of variability of NT-proANP and GDF15 in stable chronic heart failure

  2009cites this paper
• Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.

  2009cites this paper
• Guías de prácticas de laboratorio clínico: Biomarcadores de síndromes coronarios agudos y falla cardíaca

  2009cites this paper
• Inter-relações e variabilidade do estado nutricional, colesterolemia, actividade neuro-humoral e pró-inflamatória na Insuficiência Cardíaca

  2009cites this paper
• Within-person variation of the plasma concentration of B-type natriuretic peptide: safety range in stable patients with heart failure.

  2009cites this paper
• [B-type natriuretic peptide assessment in the diagnosis of rejection after pediatric heart transplant].

  2009cites this paper
• Integration of Automatic Intrathoracic Fluid Content Measurement into Clinical Decision Making in Patients with Congestive Heart Failure

  2008cites this paper
• Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurement.

  2008cites this paper
• Natriuretic Peptide Testing in Primary Care

  2008cites this paper
• B-type natriuretic Peptide: application in the community.

  2008cites this paper
• Right and left cardiac function in HIV‐infected patients investigated using radionuclide ventriculography and brain natriuretic peptide: a 5‐year follow‐up study

  2008cites this paper
• Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure National Academy of Clinical Biochemistry Laboratory Medicine Practice

  2008cites this paper
• Natriuretic peptide testing in emergency settings

  2008cites this paper
• Advances in heart failure: natriuretic peptide testing.

  2008cites this paper
• Use of B-type natriuretic peptide outside of the emergency department.

  2008cites this paper
• Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.

  2008cites this paper
• Relevance of short-term variation of B-type natriuretic peptide in patients with clinically stable heart failure

  2008influential citation
• Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure.

  2008cites this paper
• Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure.

  2008cites this paper
• Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure.

  2008cites this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.

  2008cites this paper
• Design and methodology of the NorthStar Study: NT-proBNP stratified follow-up in outpatient heart failure clinics -- a randomized Danish multicenter study.

  2008cites this paper
• The National Academy of Clinical Biochemistry

  2007cites this paper
• Variability of NT-proBNP levels in heart failure: implications for clinical application

  2007cites this paper
• National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.

  2007cites this paper
• N‐terminal pro‐B‐type natriuretic peptide in patients with growth hormone disturbances

  2007cites this paper
• Clinical Status and B-Type Natriuretic Peptide Levels in Patients with Heart Failure at Hospital Discharge

  2007cites this paper
• The year in heart failure.

  2007cites this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure WRITING GROUP MEMBERS

  2007cites this paper
• Practice Guidelines : Clinical Utilization of Cardiac Biomarker Testing in Heart Failure WRITING GROUP MEMBERS

  2007cites this paper
• Risk stratification in secondary prevention: advances in multimarker profiles, or back to basics?

  2006cites this paper
• Risk Stratification in Secondary Prevention

  2006cites this paper
• The year in heart failure.

  2005cites this paper
• BNP and NT-proBNP : Clinical Applications in ( Suspicion of ) Heart Failure

  year unknowncites this paper